Neema Ghorbani Mojarrad
Overview
Explore the profile of Neema Ghorbani Mojarrad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
89
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Plotnikov D, Williams C, Atan D, Davies N, Ghorbani Mojarrad N, Guggenheim J
Invest Ophthalmol Vis Sci
. 2020 Sep;
61(11):7.
PMID: 32886096
Purpose: Cross-sectional and longitudinal studies have consistently reported an association between education and myopia. However, conventional observational studies are at risk of bias due to confounding by factors such as...
2.
Bruce A, Ghorbani Mojarrad N, Santorelli G
BMC Ophthalmol
. 2020 Jul;
20(1):269.
PMID: 32641126
Background: A recent Genome-wide association meta-analysis (GWAS) of refractive error reported shared genetics with anthropometric traits such as height, BMI and obesity. To explore a potential relationship with refractive error...
3.
Evidence That Emmetropization Buffers Against Both Genetic and Environmental Risk Factors for Myopia
Pozarickij A, Enthoven C, Ghorbani Mojarrad N, Plotnikov D, Tedja M, Haarman A, et al.
Invest Ophthalmol Vis Sci
. 2020 Feb;
61(2):41.
PMID: 32097480
Purpose: To test the hypothesis that emmetropization buffers against genetic and environmental risk factors for myopia by investigating whether risk factor effect sizes vary depending on children's position in the...
4.
Ghorbani Mojarrad N, Plotnikov D, Williams C, Guggenheim J
JAMA Ophthalmol
. 2019 Nov;
138(1):7-13.
PMID: 31670792
Importance: Myopia is a leading cause of untreatable visual impairment and is increasing in prevalence worldwide. Interventions for slowing childhood myopia progression have shown success in randomized clinical trials; hence,...
5.
Ghorbani Mojarrad N, Williams C, Guggenheim J
Ophthalmic Physiol Opt
. 2018 Sep;
38(5):492-502.
PMID: 30182516
Purpose: To investigate whether a genetic risk score (GRS) improved performance of predicting refractive error compared to knowing a child's number of myopic parents (NMP) alone. Methods: This was a...
6.
Guggenheim J, Ghorbani Mojarrad N, Williams C, Flitcroft D
Ophthalmic Physiol Opt
. 2017 Aug;
37(5):549-556.
PMID: 28836387
No abstract available.